The board of directors of SSY Group Limited announced that the Group has obtained the approval for drug production and registration for Sodium Bicarbonate Ringer's Injection (500ml) from the National Medical Products Administration of China, being under type 3 chemical drug and regarded as passing the consistency evaluation. Sodium Bicarbonate Ringer's Injection is mainly used for replenishing extracellular fluid when circulating blood volume and interstitial fluid decrease, and for correction of metabolic acidosis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.78 HKD | +0.21% | +1.92% | -3.24% |
Apr. 23 | SSY Group Get Production, Registration Approval for Pneumonia Drug from Chinese Regulator | MT |
Apr. 16 | SSY Group Logs Nearly 15% Boost in Q1 Profit | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.24% | 1.81B | |
+26.47% | 664B | |
+30.75% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+14.45% | 234B | |
+5.15% | 199B | |
-10.06% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- 2005 Stock
- News SSY Group Limited
- SSY Group Limited Provides Update on Product Development